Drug
Lexucitug clinical trials
Also written DCSZ11.
- studies test it
- 3
- open now
- 3
- in phase 3
- 0
- first study started
- 2023
Keep track of what changes. Save the lexucitug studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2023 (1)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · West China Hospital (1) · DynamiCure Biotechnology (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses lexucitug is read from its arms, and is right about nine times in ten.
Testing it · 3
- Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal CancerNot yet recruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07580339Written as DCSZ11
- DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid TumorsRecruitingPhase 1/2West China HospitalNCT07035249Written as Low Dose DCSZ11
- DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid TumorsRecruitingPhase 1DynamiCure BiotechnologyNCT05785754Written as DCSZ11
Codes
What other systems call lexucitug · ClinicalTrials.gg INT018390
- UNII (FDA) WVR9WQ2A7WLEXUCITUGOne source FDA
- NCI Thesaurus C191907LexucitugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | WVR9WQ2A7W | LEXUCITUG | One source FDA |
| NCI Thesaurus | C191907 | Lexucitug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.